FOCL
EDAP TMS S.A. American Depositary Shares
EDAP TMS S.A. American Depositary Shares (FOCL) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 70.5 (overbought), with 3/3 trend checks passing.
FOCL with MA50 and MA200
Key levels & signals
FOCL valuation multiples (TTM)
FOCL analyst consensus
EDAP TMS S.A. American Depositary Shares (FOCL) is still trading in a constructive trend overall. The latest available price is $5.35, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 15.0% and above the 200-day moving average by 49.6%.
FOCL currently has an RSI reading of 70.5, which suggests stronger momentum and a more stretched short-term backdrop. Trend traders may still find that attractive, while more patient traders may prefer to wait and see whether the stock cools off first.
For traders reviewing FOCL next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.
About EDAP TMS S.A. American Depositary Shares
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
FOCL shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about FOCL
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.